Clinical Trials in Arkhangelsk, Russia
15 recruiting
Showing 1–15 of 15 trials
Recruiting
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
Breast Cancer
Novartis Pharmaceuticals2,766 enrolled37 locationsNCT06930859
Recruiting
Phase 1
A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
Metastatic Colorectal Cancer
R-Pharm180 enrolled26 locationsNCT07543744
Recruiting
Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Chronic Lymphocytic LeukemiaMantle Cell LymphomaFollicular Lymphoma+1 more
Janssen Research & Development, LLC700 enrolled174 locationsNCT01804686
Recruiting
Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia
Neurofibromatosis
AstraZeneca200 enrolled13 locationsNCT07088991
Recruiting
TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
Bladder Cancer
AstraZeneca600 enrolled19 locationsNCT07038928
Recruiting
Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
Prostate Cancer
AstraZeneca400 enrolled18 locationsNCT07052578
Recruiting
An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation
Endometrial Cancer
AstraZeneca500 enrolled21 locationsNCT07041606
Recruiting
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
AstraZeneca2,000 enrolled41 locationsNCT05887011
Recruiting
Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation
Prostate Cancer
AstraZeneca400 enrolled17 locationsNCT07146113
Recruiting
Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Schizophrenia
Gedeon Richter Plc.330 enrolled57 locationsNCT03817502
Recruiting
Phase 2
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
Biocad124 enrolled47 locationsNCT07108309
Recruiting
Phase 2Phase 3
REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis
Diabetic Ketoacidosis
POLYSAN Scientific & Technological Pharmaceutical Company312 enrolled3 locationsNCT06955416
Recruiting
Russian Registry of Surgical OutcomeS
SurgeryAnesthesiaComplication+1 more
Russian Federation of Anesthesiologists and Reanimatologists162,000 enrolled16 locationsNCT06146270
Recruiting
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Coronary Heart DiseaseEpilepsyStroke+4 more
Russian Federation of Anesthesiologists and Reanimatologists16,000 enrolled38 locationsNCT03945968
Recruiting
Phase 3
A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
Mabscale, LLC620 enrolled28 locationsNCT05654454